头孢哌酮-舒巴坦治疗下呼吸道感染的疗效评价

目的 :观察头孢哌酮 -舒巴坦治疗下呼吸道感染的疗效及耐药性。方法 :下呼吸道感染病人 32例 ,用头孢哌酮 -舒巴坦 2 .0 g加入 5 %葡萄糖 2 5 0 m L 中静脉滴注 bid,疗程 7～ 14天 ;分离的细菌用纸片法测定药物敏感性。结果 :头孢哌酮 -舒巴坦治疗总有效率为 94% ,细菌清除率为 83%。结论 :头孢哌酮 -舒巴坦对下呼吸道感染疗效好 ,细菌耐药性低。

Evaluation of Clinical Therapeutic Effect of Cefoperazone Sodium/Sulbactam Sodium in Treating Lower Respiratory Tract Infections

Objective: To observe the efficacy and drug resistance of Cefoperazone Sodium/Sulbactam Sodium injection in the treatment of lower respiratory tract infection. Methods: Thirty-two patients with lower respiratory tract infection were treated with 2.0g Cefoperazone Sodium/Sulbactam Sodium added to 5% Glucose and intrarenous drip, twice a day for 7～14d. Drug sensitivity against the isolatedstrains for Kirby-Bauer method was studied. Results: The overall clinical efficacy rates of Cefoperazone Sodium/Sulbactam Sodium was 94%. The bacterial clearance rate for Cefoperazone Sodium/Sulbactam Sodium was 83%. Conclusion: Cefoperazone Sodium/Sulbactam Sodium for injection is an effective antibacterial therapy for the treatment of lower respiratory tract infection and drug resistance of bacteria is lower.